Dicle Universitesi Tip Fakultesi

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease1 trial
• Gastric and oesophageal cancer1 trial
• Obesity1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Amgen1 trial
• Boehringer Ingelheim1 trial

Closed trials

• Completed

  A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

  NCT06077864· Phase 3· Boehringer Ingelheim· Source

• Completed

  Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

  NCT05052801· Phase 3· Amgen· Source